Staphylococcal superantigens and the diseases they cause

The Comprehensive Sourcebook of Bacterial Protein Toxins

Volumn , Issue , 2006, Pages 830-843

  Uchiyama, Takehiko ^a   Imanishi, Ken'ichi ^a   Kato, Hidehito ^a   Miyoshi Akiyama, Tohru ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 55849143423     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088445-2/50055-X     Document Type: Chapter

References (91)

1. Abe J., Takeda T., Watanabe Y., Nakao H., Kobayashi N., Leung D.Y., Kohsaka T. Evidence for superantigen production by Yersinia pseudotuberculosis. J. Immunol. 1993, 151:4183-4188.
2. Abe J., Onimaru M., Matsumoto S., Noma S., Baba K., Ito Y., Kohsaka T., Takeda T. Clinical role for a superantigen in Yersinia pseudotuberculosis infection. J. Clin. Invest. 1997, 99:1823-1830.
3. Alber G., Hammer D.K., Fleischer B. Relationship between enterotoxic and T lymphocyte-stimulating activity of staphylococcal enterotoxin B. J. Immunol. 1990, 144:4501-4506.
4. Alouf J.E., Muller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological, and clinical aspects. Int. J. Med. Microbiol. 2003, 292:429-440.
5. Arcus V.I., Langley R., Proft T., Fraser J.D., Baker E.N. The three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genome. J. Biol. Chem. 2002, 277:32274-32281.
6. Baba T., Takeuchi F., Kuroda M., Yuzawa H., Aoki K., Oguchi A., Nagai Y., Iwama N., Asano K., Naimi T., Kuroda H., Cui L., Yamamoto K., Hiramatsu K. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002, 359:1819-1827.
7. Bayles K.W., Landolo J.J. Genetic and molecular analyses of the gene encoding staphylococcal enterotoxin D. J. Bacteriol. 1989, 171:4799-4806.
8. Bergdoll M.S. Staphylococcal intoxications. Food-borne Infections and Intoxications 1979, 443-494. Academic Press, London. H. Riemann, F.L. Bryan (Eds.).
9. Bergdoll M.S., Crass B.A., Reiser R.F., Robbins R.N., Davis J.P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic shock syndrome Staphylococcus aureus isolates. Lancet 1981, 1:1017-1021.
10. Betley M.J., Mekalanos J.J. Nucleotide sequence of the type A staphylococcal enterotoxin gene. J. Bacteriol. 1988, 170:34-41.
11. Blomster-Hautamaa D.A., Kreiswirth B.N., Kornblum J.S., Novick R.P., Schlievert P.M. The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J. Biol. Chem. 1986, 261:15783-15786.
12. Bohach G.A., Schlievert P.M. Nucleotide sequence of the staphylococcal enterotoxin C1 gene and relatedness to other pyrogenic toxins. Mol. Gen. Genet. 1987, 209:15-20.
13. Bohach G.A., Schlievert P.M. Conservation of the biologically active portions of staphylococcal enterotoxins C1 and C2. Infect. Immun. 1989, 57:2249-2252.
14. Bonventre P.F., Weckbach L., Staneck J., Schlievert P.M., Thompson M. Production of staphylococcal enterotoxin F and pyrogenic exotoxin C by Staphylococcus aureus isolates from toxic shock syndrome-associated sources. Infect. Immun. 1983, 40:1023-1029.
15. Burnet F.M. The Clonal Selection Theory of Acquired Immunity 1959, Cambridge University Press, New York.
16. Calvano S.E., Quimby F.W., Antonacci A.C., Reiser R.F., Bergdoll M.S., Dineen P. Analysis of the mitogenic effects of toxic shock toxin on human peripheral blood mononuclear cells in vitro. Clin. Immunol. Immunopathol. 1984, 33:99-110.
17. + T cells. J. Immunol. 2002, 168:3817-3824.
18. Choi Y., Lafferty J.A., Clements J.R., Todd J.K., Gelfand E.W., Kappler J., Marrack P., Kotzin B.L. Selective expansion of T cells expressing Vβ 2 in toxic shock syndrome. J. Exp. Med. 1990, 172:981-984.
19. Cohen M.L., Graves L.M., Hayes P.S., Gibson R.J., Rasheed J.K., Feeley J.C. Toxic shock syndrome: modification and comparison of methods for detecting marker proteins in Staphylococcus aureus. J. Clin. Microbiol. 1983, 18:372-375.
20. Cole B.C., Atkin C.L. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol. Today. 1991, 12:271-276.
21. Couch J.L., Soltis M.T., Betley M.J. Cloning and nucleotide sequence of the type E staphylococcal enterotoxin gene. J. Bacteriol. 1988, 170:2954-2960.
22. Crass B.A., Bergdoll M.S. Involvement of coagulase-negative staphylococci in toxic shock syndrome. J. Clin. Microbiol. 1986, 23:43-45.
23. Davis D., Gash-Kim T.L., Heffernan E.J. Toxic shock syndrome: case report of a postpartum female and a literature review. J. Emerg. Med. 1998, 16:607-614.
24. Edwards V.M., Deringer J.R., Callantine S.D., Deobald C.F., Berger P.H., Kapur V., Stauffacher C.V., Bohach G.A. Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates. Infect. Immun. 1997, 65:2346-2352.
25. Fraser J.D. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 1989, 339:221-223.
26. + T cells. J. Biol. Chem. 2001, 276:17455-17460.
27. Gutterman J.U., Blumenschein G.R., Alexanian R., Yap H.Y., Buzdar A.U., Cabanillas F., Hortobagyi G.N., Hersh E.M., Rasmussen S.L., Harmon M., Kramer M., Pestka S. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann. Intern. Med. 1980, 93:399-406.
28. Hajjeh R.A., Reingold A., Weil A., Shutt K., Schuchat A., Perkins B.A. Toxic shock syndrome in the United States: surveillance update, 1979, 1996. Emerg. Infect. Dis. 1999, 5:807-810.
29. Harris T.O., Betley M.J. Biological activities of staphylococcal enterotoxin type A mutants with N-terminal substitutions. Infect. Immun. 1995, 63:2133-2140.
30. Held W., Acha-Orbea H., MacDonald H.R., Waanders G.A. Superantigens and retroviral infection: insights from mouse mammary tumor virus. Immunol. Today. 1994, 15:184-190.
31. Herrmann T., Accolla R.S., MacDonald H.R. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes. Eur. J. Immunol. 1989, 19:2171-2174.
32. Hoffman M., Tremaine M., Mansfield J., Betley M. Biochemical and mutational analysis of the histidine residues of staphylococcal enterotoxin A. Infect. Immun. 1996, 64:885-890.
33. Hovde C.J., Hackett S.P., Bohach G.A. Nucleotide sequence of the staphylococcal enterotoxin C3 gene: sequence comparison of all three type C staphylococcal enterotoxins. Mol. Gen. Genet. 1990, 220:329-333.
34. Hovde C.J., Marr J.C., Hoffmann M.L., Hackett S.P., Chi Y.I., Crum K.K., Stevens D.L., Stauffacher C.V., Bohach G.A. Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1. Mol. Microbiol. 1994, 13:897-909.
35. Imanishi K., Igarashi H., Uchiyama T. Activation of murine T cells by streptococcal pyrogenic exotoxin type A. Requirement for MHC class II molecules on accessory cells and identification of Vβ elements in T cell receptor of toxin-reactive T cells. J. Immunol. 1990, 145:3170-3176.
36. + T cells. J. Immunol. 1998, 160:112-119.
37. Jarraud S., Cozon G., Vandenesch F., Bes M., Etienne J., Lina G. Involvement of enterotoxins G and I in staphylococcal toxic shock syndrome and staphylococcal scarlet fever. J. Clin. Microbiol. 1999, 37:2446-2449.
38. Jarraud S., Peyrat M.A., Lim A., Tristan A., Bes M., Mougel C., Etienne J., Vandenesch F., Bonneville M., Lina G. egc, a highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J. Immunol. 2001, 166:669-677.
39. Correction J. Immunol. 2001, 166:4260.
40. Kappler J., Kotzin B., Herron L., Gelfand E.W., Bigler R.D., Boylston A., Carrel S., Posnett D.N., Choi Y., Marrack P. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989, 244:811-813.
41. Kato H., Takahashi N., Arimura Y., Imanishi K., Nishida H., Uchiyama T. The percentage of superantigen-reactive T cells in peripheral blood significantly decreases before massively increasing in patients with neonatal TSS-like exanthematous disease in the early acute phase. J. Infect. Chemother. 2002, 8:111-114.
42. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 1991, 349:245-248.
43. Kobayashi S., Ohnuma K., Uchiyama M., Iino K., Iwata S., Dang N.H., Morimoto C. Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T cell activation. Blood 2004, 103:1002-1010.
44. Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L., Oguchi A., Aoki K., Nagai Y., Lian J., Ito T., Kanamori M., Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y., Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K., Hirakawa H., Kuhara S., Goto S., Yabuzaki J., Kanehisa M., Yamashita A., Oshima K., Furuya K., Yoshino C., Shiba T., Hattori M., Ogasawara N., Hayashi H., Hiramats K. Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet 2001, 357:1225-1240.
45. Larkin S.M., Williams D.N., Osterholm M.T., Tofte R.W., Posalaky Z. Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases. Ann. Intern. Med. 1982, 96:858-864.
46. Letertre C., Perelle S., Dilasser F., Fach P. Identification of a new putative enterotoxin SEU encoded by the egc cluster of Staphylococcus aureus. J. Appl. Microbiol. 2003, 95:38-43.
47. Lina G., Bohach G.A., Nair S.P., Hiramatsu K., Jouvin-Marche E., Mariuzza R. Standard nomenclature for the superantigens expressed by Staphylococcus. J. Infect. Dis. 2004, 189:2334-2336.
48. Lindsay J.A., Ruzin A., Ross H.F., Kurepina N., Novick R.P. The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol. Microbiol. 1998, 29:527-543.
49. Lotze M.T., Matory Y.L., Ettinghausen S.E., Rayner A.A., Sharrow S.O., Seipp C.A., Custer M.C., Rosenberg S.A. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. J. Immunol. 1985, 135:2865-2875.
50. Marrack P., Blackman M., Kushnir E., Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp. Med. 1990, 171:455-464.
51. Matsuda Y., Kato H., Yamada R., Okano H., Ohta H., Imanishi K., Kikuchi K., Totsuka K., Uchiyama T. Early and definitive diagnosis of toxic shock syndrome by detection of marked expansion of T cell receptor Vβ2-positive T cells. Emerg. Infect. Dis. 2003, 9:387-389.
52. McCormick J.K., Yarwood J.M., Schlievert P.M. Toxic shock syndrome and bacterial superantigens: an update. Annu. Rev. Microbiol. 2001, 55:77-104.
53. Miyoshi-Akiyama T., Abe A., Kato H., Kawahara K., Narimatsu H., Uchiyama T. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM. J. Immunol. 1995, 154:5228-5234.
54. Mollick J.A., Cook R.G., Rich R.R. Class II MHC molecules are specific receptors for staphylococcus enterotoxin A. Science 1989, 244:817-820.
55. Munson S.H., Tremaine M.T., Betley M.J., Welch R.A. Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect. Immun. 1998, 66:3337-3348.
56. Omoe K., Hu D.L., Takahashi-Omoe H., Nakane A., Shinagawa K. Identification and characterization of a new staphylococcal enterotoxin-related putative toxin encoded by two kinds of plasmids. Infect. Immun. 2003, 71:6088-6094.
57. Omoe K., Imanishi K., Hu D.L., Kato H., Takahashi-Omoe H., Nakane A., Uchiyama T., Shinagawa K. Biological properties of staphylococcal enterotoxin-like toxin type R. Infect. Immun. 2004, 72:3664-3667.
58. Omoe K., Imanishi K., Mu D.L., Kato H., Fugane Y., Abe Y., Hamaoka S., Watanabe Y., Nakane A., Uchiyama T., Shinagawa K. Infect Immun. 2005, (In press).
59. Orwin P.M., Leung D.Y., Donahue H.L., Novick R.P., Schlievert P.M. Biochemical and biological properties of Staphylococcal enterotoxin K. Infect. Immun. 2001, 69:360-366.
60. Orwin P.M., Leung D.Y., Tripp T.J., Bohach G.A., Earhart C.A., Ohlendorf D.H., Schlievert P.M. Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. Biochemistry 2002, 41:14033-14040.
61. Orwin P.M., Fitzgerald J.R., Leung D.Y., Gutierrez J.A., Bohach G.A., Schlievert P.M. Characterization of Staphylococcus aureus enterotoxin L. Infect. Immun. 2003, 71:2916-2919.
62. Paris A.L., Herwaldt L.A., Blum D., Schmid G.P., Shands K.N., Broome C.V. Pathologic findings in twelve fatal cases of toxic shock syndrome. Ann. Intern. Med. 1982, 96:852-857.
63. Parsonnet J., Gillis Z.A., Richter A.G., Pier G.B. A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect. Immun. 1987, 55:1070-1076.
64. Petersson K., Pettersson H., Skartved N.J., Walse B., Forsberg G. Staphylococcal enterotoxin H induces Vα-specific expansion of T cells. J. Immunol. 2003, 170:4148-4154.
65. Poindexter N.J., Schlievert P.M. Toxic shock syndrome toxin 1-induced proliferation of lymphocytes: comparison of the mitogenic response of human, murine, and rabbit lymphocytes. J. Infect. Dis. 1985, 151:65-72.
66. Proft T., Fraser J.D. Bacterial superantigens. Clin. Exp. Immunol. 2003, 133:299-306.
67. Ranelli D.M., Jones C.L., Johns M.B., Mussey G.J., Khan S.A. Molecular cloning of staphylococcal enterotoxin B gene in Escherichia coli and Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 1985, 82:5850-5854.
68. Rasheed J.K., Arko R.J., Feeley J.C., Chandler F.W., Thornsberry C., Gibson R.J., Cohen M.L., Jeffries C.D., Broome C.V. Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model. Infect. Immun. 1985, 47:598-604.
69. Rellahan B.L., Jones L.A., Kruisbeek A.M., Fry A.M., Matis L.A. In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J. Exp. Med. 1990, 172:1091-1100.
70. Ren K., Bannan J.D., Pancholi V., Cheung A.L., Robbins J.C., Fischetti V.A., Zabriskie J.B. Characterization and biological properties of a new staphylococcal exotoxin. J. Exp. Med. 1994, 180:1675-1683.
71. Schlievert P.M., Shands K.N., Dan B.B., Schmid G.P., Nishimura R.D. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J. Infect. Dis. 1981, 143:509-516.
72. Schlievert P.M., Tripp T.J., Peterson M.L. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J. Clin. Microbiol. 2004, 42:2875-2876.
73. Scholl P., Diez A., Mourad W., Parsonnet J., Geha R.S., Chatila T. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci. USA 1989, 86:4210-4214.
74. Shands K.N., Schmid G.P., Dan B.B., Blum D., Guidotti R.J., Hargrett N.T., Anderson R.L., Hill D.L., Broome C.V., Band J.D., Fraser D.W. Toxic shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N. Engl. J. Med. 1980, 303:1436-1442.
75. Su Y.C., Wong A.C. Identification and purification of a new staphylococcal enterotoxin, H. Appl. Environ. Microbiol. 1995, 61:1438-1443.
76. Takahashi N., Imanishi K., Nishida H., Uchiyama T. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J. Immunol. 1995, 155:5213-5219.
77. Takahashi N., Nishida H., Ino M., Sakata Y., Sakuma I., Takeda Y. A new exanthematous disease in newborn infants. Acta Neonatal. Jpn. 1995, 31:371-377.
78. Takahashi N., Nishida H., Kato H., Imanishi K., Sakata Y., Uchiyama T. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 1998, 351:1614-1619.
79. Takahashi N., Kato H., Imanishi K., Miwa K., Yamanami S., Nishida H., Uchiyama T. Immunopathophysiological aspects of an emerging neonatal infectious disease induced by a bacterial superantigen. J. Clin. Invest. 2000, 106:1409-1415.
80. Todd J., Fishaut M., Kapral F., Welch T. toxic shock syndrome associated with phage group-I Staphylococci. Lancet 1978, 2:1116-1118.
81. Todd J.K. Toxic shock syndrome. Clin. Microbiol. Rev. 1988, 1:432-446.
82. Tofte R.W., Williams D.N. Toxic shock syndrome. Evidence of a broad clinical spectrum. JAMA 1981, 246:2163-2167.
83. Uchiyama T., Kamagata Y., Wakai M., Yoshioka M., Fujikawa H., Igarashi H. Study of the biological activities of toxic shock syndrome toxin-1. I. Proliferative response and interleukin 2 production by T cells stimulated with the toxin. Microbiol. Immunol. 1986, 30:469-483.
84. Uchiyama T., Kamagata Y., Yan X.J., Kohno M., Yoshioka M., Fujikawa H., Igarashi H., Okubo M., Awano F., Saito-Taki T., Nakano M. Study of the biological activities of toxic shock syndrome toxin-1. II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin. Clin. Exp. Immunol. 1987, 68:638-647.
85. Uchiyama T., Imanishi K., Saito S., Araake M., Yan X.J., Fujikawa H., Igarashi H., Kato H., Obata F., Kashiwagi N., Inoko H. Activation of human T cells by toxic shock syndrome toxin-1: the toxin-binding structures expressed on human lymphoid cells acting as accessory cells are HLA class II molecules. Eur. J. Immunol. 1989, 19:1803-1809.
86. Uchiyama T., Tadakuma T., Imanishi K., Araake M., Saito S., Yan X.J., Fujikawa H., Igarashi H., Yamaura N. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules. J. Immunol. 1989, 143:3175-3182.
87. Uchiyama T., Miyoshi-Akiyama T., Kato H., Fujimaki W., Imanishi K., Yan X.J. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J. Immunol. 1993, 151:4407-4413.
88. Uchiyama T., Yan X.J., Imanishi K., Yagi J. Bacterial superantigens-mechanism of T cell activation by the superantigens and their role in the pathogenesis of infectious diseases. Microbiol. Immunol. 1994, 38:245-256.
89. White J., Herman A., Pullen A.M., Kubo R., Kappler J.W., Marrack P. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and donal deletion in neonatal mice. Cell 1989, 56:27-35.
90. Williams R.J., Ward J.M., Henderson B., Poole S., O'Hara B.P., Wilson M., Nair S.P. Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect. Immun. 2000, 68:4407-4415.
91. Zhang S., Iandolo J.J., Stewart G.C. The enterotoxin D plasmid of Staphylococcus aureus encodes a second enterotoxin determinant (sej). FEMS Microbiol. Lett. 1998, 168:227-233.